Loading provider…
Loading provider…
Hematology & Oncology Physician in La Mesa, CA
NPI: 1164583639Primary Practice Location
GROSSMONT HOSPITAL
5555 Grossmont Center Dr, La Mesa, CA
Primary Employer
Cancer Center Oncology Medical Group, Inc-East County
grossmontcancercenter.com
HQ Phone
Get M.D. Kai's Phone Numberphone_androidMobile
Get M.D. Kai's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2001 - 2027
VA State Medical License
2000 - 2001

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of California (San Diego) Medical Center
Fellowship • Hematology and Medical Oncology
2001 - 2004
University of Virginia Medical Center
Fellowship • Infectious Disease
2000 - 2001
Stony Brook Medicine/University Hospital
Residency • Internal Medicine
1997 - 2000
Shanghai Medical University
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 379 | 803 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 175 | 263 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 98 | 98 |
| 4 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 67 | 485 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 55 | 58 |
Authors: Zu, Kai, Greenwood, Kristina L, LaMori, Joyce C, Smith, Besa, Smith, Tyler, Lee, Alaina
Journal: JCO Clin Cancer Inform
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: M7824
Lead Sponsor: GlaxoSmithKline
Intervention / Treatment: DRUG: Placebo, DRUG: Fulvestrant, DRUG: GSK525762
Lead Sponsor: Aptose Biosciences Inc.
Intervention / Treatment: DRUG: CG-806